Cross A
Virulence. 2013; 5(1):219-25.
PMID: 23974910
PMC: 3916378.
DOI: 10.4161/viru.25965.
Novik V, Hofreuter D, Galan J
Infect Immun. 2009; 77(12):5428-36.
PMID: 19797067
PMC: 2786475.
DOI: 10.1128/IAI.00528-09.
osawa E, MUSCHEL L
J Exp Med. 1964; 119:41-51.
PMID: 14115824
PMC: 2137802.
DOI: 10.1084/jem.119.1.41.
Cross A, Opal S, Sadoff J, Gemski P
Infect Immun. 1993; 61(7):2741-7.
PMID: 8514375
PMC: 280916.
DOI: 10.1128/iai.61.7.2741-2747.1993.
Cross A, Asher L, Seguin M, Yuan L, Kelly N, Hammack C
J Clin Invest. 1995; 96(2):676-86.
PMID: 7635960
PMC: 185248.
DOI: 10.1172/JCI118110.
Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae.
Saxen H, Makela P, Leive L
Infect Immun. 1983; 41(2):563-9.
PMID: 6347890
PMC: 264679.
DOI: 10.1128/iai.41.2.563-569.1983.
Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.
Taylor P
Microbiol Rev. 1983; 47(1):46-83.
PMID: 6343827
PMC: 281561.
DOI: 10.1128/mr.47.1.46-83.1983.
Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen.
Goldman R, Joiner K, Leive L
J Bacteriol. 1984; 159(3):877-82.
PMID: 6207166
PMC: 215740.
DOI: 10.1128/jb.159.3.877-882.1984.
[Serum resistance and "nephropathogenicity" of antigenically defined strains of E. coli. I. Determination and standardization of serum sensitivity].
Henkel W
Z Med Mikrobiol Immunol. 1970; 156(1):44-59.
PMID: 4921691
Mouse virulence of K(L) antigen-containing strains of Escherichia coli.
Wolberg G, Dewitt C
J Bacteriol. 1969; 100(2):730-7.
PMID: 4901357
PMC: 250151.
DOI: 10.1128/jb.100.2.730-737.1969.
Activity of mitomycin C, other antibiotics, and serum against lysogenic bacteria.
MUSCHEL L, SCHMOKER K
J Bacteriol. 1966; 92(4):967-71.
PMID: 4288803
PMC: 276362.
DOI: 10.1128/jb.92.4.967-971.1966.
Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum.
Ciurana B, Tomas J
Infect Immun. 1987; 55(11):2741-6.
PMID: 3312009
PMC: 259970.
DOI: 10.1128/iai.55.11.2741-2746.1987.
Experimental Escherichia coli endocarditis in rats: roles of serum bactericidal activity and duration of catheter placement.
Yersin B, Glauser M, Guze P, Guze L, FREEDMAN L
Infect Immun. 1988; 56(5):1273-80.
PMID: 3281906
PMC: 259807.
DOI: 10.1128/iai.56.5.1273-1280.1988.
Determination of serum bactericidal activity against Escherichia coli by an automated photometric method.
Crokaert F, Lismont M, Linden M, Yourassowsky E
J Clin Microbiol. 1988; 26(10):2069-76.
PMID: 3053761
PMC: 266818.
DOI: 10.1128/jcm.26.10.2069-2076.1988.
The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity.
Shaw S, Smith A, Anderson P, Smith D
J Clin Invest. 1976; 58(4):1019-29.
PMID: 1085778
PMC: 333266.
DOI: 10.1172/JCI108525.
Protective role of complement in experimental Escherichia coli endocarditis.
Durack D, Beeson P
Infect Immun. 1977; 16(1):213-7.
PMID: 326670
PMC: 421510.
DOI: 10.1128/iai.16.1.213-217.1977.
